30 Jan 2013
ERJ staff report (BC)
Microban International has carried out in vitro
testing to simulate planktonic and biofilm growth on high-consistency rubber (HCR) silicone, reports Lou Reade in PRW.
The silicone is often used to make urinary catheters. Urinary infections are an expensive source of hospital-acquired infections, and existing technologies have had limited success in reducing infection rates.
Microban's silver antimicrobial technology, developed for HCR silicone, is engineered to meet stricter FDA guidelines that encourage manufacturers to adopt tougher measures in order to reduce patient infection.
Initial results with the antimicrobial technology exceed FDA guidelines, says the company, showing greater than 5 log reductions in Proteus vulgaris, Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli versus unprotected HCR silicone.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Subscribe for unlimited access. A subscription to European Rubber Journal includes:
Already a subscriber? Log in here
